Your browser doesn't support javascript.
Strategy To Assess Zoonotic Potential Reveals Low Risk Posed by SARS-Related Coronaviruses from Bat and Pangolin.
Yang, Yong; Shen, Xu-Rui; Zhang, Yu-Lan; Jiang, Ren-di; Wang, Xi; Guan, Zhen-Qiong; Li, Qian; Yao, Yu-Lin; Gong, Qian-Chun; Geng, Rong; Wang, Qi; Zhu, Yan; Luo, Jing-Yi; Shi, Zheng-Li; Zhang, Hui-Lan; Peng, Ke; Zhou, Peng.
  • Yang Y; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Shen XR; University of Chinese Academy of Sciences, Beijing, China.
  • Zhang YL; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Jiang RD; University of Chinese Academy of Sciences, Beijing, China.
  • Wang X; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Guan ZQ; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
  • Li Q; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Yao YL; University of Chinese Academy of Sciences, Beijing, China.
  • Gong QC; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Geng R; University of Chinese Academy of Sciences, Beijing, China.
  • Wang Q; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Zhu Y; University of Chinese Academy of Sciences, Beijing, China.
  • Luo JY; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Shi ZL; State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China.
  • Zhang HL; Center for Organoid and Regenerative Medicine, Greater Bay Area Institute of Precision Medicine, Guangzhou, China.
  • Peng K; CAS Key Laboratory of Special Pathogens and State Key Laboratory of Virology, Center for Antiviral Research, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, Hubei, China.
  • Zhou P; University of Chinese Academy of Sciences, Beijing, China.
mBio ; 14(2): e0328522, 2023 04 25.
Article in English | MEDLINE | ID: covidwho-2246542
ABSTRACT
In the last 2 decades, pathogens originating in animals may have triggered three coronavirus pandemics, including the coronavirus disease 2019 pandemic. Thus, evaluation of the spillover risk of animal severe acute respiratory syndrome (SARS)-related coronavirus (SARSr-CoV) is important in the context of future disease preparedness. However, there is no analytical framework to assess the spillover risk of SARSr-CoVs, which cannot be determined by sequence analysis alone. Here, we established an integrity framework to evaluate the spillover risk of an animal SARSr-CoV by testing how viruses break through key human immune barriers, including viral cell tropism, replication dynamics, interferon signaling, inflammation, and adaptive immune barriers, using human ex vivo lung tissues, human airway and nasal organoids, and human lung cells. Using this framework, we showed that the two pre-emergent animal SARSr-CoVs, bat BtCoV-WIV1 and pangolin PCoV-GX, shared similar cell tropism but exhibited less replicative fitness in the human nasal cavity or airway than did SARS-CoV-2. Furthermore, these viruses triggered fewer proinflammatory responses and less cell death, yet showed interferon antagonist activity and the ability to partially escape adaptive immune barriers to SARS-CoV-2. Collectively, these animal viruses did not fully adapt to spread or cause severe diseases, thus causing successful zoonoses in humans. We believe that this experimental framework provides a path to identifying animal coronaviruses with the potential to cause future zoonoses. IMPORTANCE Evaluation of the zoonotic risk of animal SARSr-CoVs is important for future disease preparedness. However, there are misconceptions regarding the risk of animal viruses. For example, an animal SARSr-CoV could readily infect humans. Alternately, human receptor usage may result in spillover risk. Here, we established an analytical framework to assess the zoonotic risk of SARSr-CoV by testing a series of virus-host interaction profiles. Our data showed that the pre-emergent bat BtCoV-WIV1 and pangolin PCoV-GX were less adapted to humans than SARS-CoV-2 was, suggesting that it may be extremely rare for animal SARSr-CoVs to break all bottlenecks and cause successful zoonoses.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Chiroptera / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Animals / Humans Language: English Journal: MBio Year: 2023 Document Type: Article Affiliation country: Mbio.03285-22

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Chiroptera / COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials Limits: Animals / Humans Language: English Journal: MBio Year: 2023 Document Type: Article Affiliation country: Mbio.03285-22